v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
Net loss $ (19,649,099) $ (20,297,040)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 1,015,907 648,025
(Gain)/loss on disposal of property and equipment (1,007) 19,668
Noncash lease expense 580,751 461,490
Interest on finance leases 496
Loss on marketable securities 69,552
Credit loss (recovery)/expense (2,409) 10,572
Loss on write-off of related party receivables 215,779
Contract modification - related party 280,545
Share-based compensation 7,183
Bargain purchase gain (2,068,047)
Write-off of demonstration equipment 441,624
Interest expense paid in equity shares 11,798,283
Accrued interest on notes payable 341,982 530,404
Non-cash royalty income (243,525) (71,464)
Amortization of original issue discounts on notes payable 221,875 16,667
Loan origination costs 25,000 5,000
Receipt of SOL from staking (31,683)
Non-cash transaction fees 6,884
Unrealized loss on digital assets 1,098,441
Loss on exercise of warrant liabilities 4,658,582 15,796,105
Changes in fair value of warrant liability (2,285,811) 5,312,838
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables 1,014,607 (1,536,888)
Trade receivables - related party 35,160 66,057
Inventory 142,207 851,764
Contract assets (566,550) (171,413)
Prepaid expenses and other current assets (492,520) (569,401)
Other assets 15,263 173,497
Accounts payable (696,851) (518,330)
Sales tax payable (25,121) (69,054)
Operating lease liabilities (582,108) (464,886)
Deposits from customers 140,401 (225,560)
Accrued expenses (586,966) 972,123
Contract liabilities 160,792 670,221
Deferred revenue (475,112) (266,217)
Income taxes payable 412,260 (38,617)
Other liabilities 517 7,243
Net cash (used in)/provided by operating activities (5,310,446) 1,600,532
Cash Flows from Investing Activities    
Purchase of property and equipment (336,782) (1,359,963)
Proceeds from sale of property and equipment 19,592 13,511
Royalties on related party revenues 40,000 10,000
Purchase of marketable securities (5,100,000)
Acquisitions, net of cash acquired (7,594,695)
Investment in digital assets (1,000,567)
Investment in MasterpieceVR (100,000)
Net cash used by investing activities (13,972,452) (1,436,452)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 10,511,864 18,925,223
Payments on revolving line of credit (12,048,307) (19,182,809)
Payments on debt (250,767) (240,510)
Finance lease liabilities (6,897)
Payments on Paycheck Protection Program Loans (20,247)
Proceeds from notes payable 7,000,000 500,000
Proceeds from warrant exercises 5,675,332 1,050,597
Proceeds from offerings 10,000,000
Expenses on offerings (9,473)
Net cash provided by financing activities 20,871,752 1,032,254
Effect of currency translation (25,777) (550,693)
Net increase in cash, cash equivalents, and restricted cash 1,588,854 1,196,334
Cash, cash equivalents, and restricted cash at beginning of period 6,347,041 5,420,392
Total cash, cash equivalents, and restricted cash 7,910,118 6,066,033
Cash and cash equivalents 6,567,030 4,538,405
Restricted cash 1,343,088 1,527,628
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 323,938 389,840
Cash paid during the period for income taxes, net of refunds 107,621 269,680
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay notes payable 19,642,283
Noncash dividends 136 123
Financing of Building Purchase 3,920,000
Financing of Acquisitions 600,000
Noncash recognition of new leases 750,580 204,726
Series A Warrant Exercises 211,098 21,515,777
Series B Warrant Exercises $ 15,828,703